In vitro, TFPI-2 has been reported to suppress breast cancer cell proliferation and invasion9, and reduced TFPI-2 expression due to deviant methylation of CpG islands in the TFPI2 promoter region in breast cancer cell lines, especially in highly invasive cells10, has been demonstrated. The gene discussed is TFPI2; the disease is breast cancer.